文献速递乳房整形与再造

乳房再造报销差异的横断面研究:医疗差距是否即将出现?

A Cross-Sectional Study of Variations in Reimbursement for Breast Reconstruction: Is A Healthcare Disparity On the Horizon?
PubMed 文献 · Ann Plast Surg · 2018-01-01

该研究收集2003至2013年10年间植入物再造(19357)或游离皮瓣再造(19364)患者的计费数据,按保险类型分为联邦医疗保险(Medicare)、医疗补助(Medicaid)和私人保险三组直接比较。共2691名女性接受乳房再造,其中71.2%为私人保险、13.3%为医疗补助、14.49%为联邦医疗保险。植入物再造的总费用平均报销比例分别为医疗补助16.3%、联邦医疗保险28.3%、私人保险67.2%;自体再造分别为12.37%、22.9%、35.35%。自体再造的报销随时间在所有支付方中显著下降,而植入物再造的报销差异正在缩小。

要点

  • 共2691名女性接受乳房再造,私人保险占71.2%、医疗补助占13.3%、联邦医疗保险占14.49%。
  • 植入物再造总费用平均报销比例:医疗补助16.3%、联邦医疗保险28.3%、私人保险67.2%。
  • 自体再造平均报销比例:医疗补助12.37%、联邦医疗保险22.9%、私人保险35.35%。

核心结论

  • 乳房再造手术的报销存在广泛差异,可能使部分外科医生不再向部分患者提供某些再造选项。
  • 理解这些差异是减少该患者群体潜在诊疗差距的关键第一步。

研究设计与样本

  • 横断面研究,收集2003年至2013年10年间接受植入物再造(19357)或游离皮瓣再造(19364)患者的计费数据。
  • 共2691名女性接受乳房再造,按保险类型分为联邦医疗保险、医疗补助和私人保险三组直接比较。

主要发现

  • 植入物再造的总费用平均报销比例:医疗补助16.3%、联邦医疗保险28.3%、私人保险67.2%。
  • 自体再造的平均报销比例:医疗补助12.37%、联邦医疗保险22.9%、私人保险35.35%。
  • 接受自体再造的医疗补助患者每小时报销估计值最低,接受植入物再造的私人保险患者每小时报销估计值最高。
  • 随时间推移,自体再造的报销在所有支付方类型中均显著下降,而植入物再造的报销差异正在缩小。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite growing demand for breast reconstruction, financial disincentives to perform breast reconstruction in patients with government-sponsored insurance plans may lead to longer wait times and decreased access to care. We identify the variation in reimbursement for implant and autologous reconstruction as a step toward understanding these financial implications, to develop safeguards to minimize effects on access to care. METHODS: Billing data were collected over a 10-year period for patients undergoing implant-based (19357) or free-flap (19364) breast reconstruction. Patients were placed into cohorts according to insurance type-Medicare, Medicaid, or private insurance, and these were directly compared. RESULTS: A total of 2691 women underwent breast reconstruction between 2003 and 2013; 71.2% had private insurance, 13.3% had Medicaid, and 14.49% had Medicare. For implant-based reconstructions, the average reimbursement of total charges was 16.3% for Medicaid, 28.3% for Medicare, and 67.2% for private insurance. For autologous reconstruction, average reimbursement was 12.37% for Medicaid, 22.9% for Medicare, and 35.35% for private insurance. Hourly reimbursement estimates for Medicaid patients undergoing autologous reconstruction were lowest. The highest hourly reimbursement estimate was for privately insured patients undergoing implant-based reconstruction. Over time, reimbursement for autologous reconstruction has declined significantly for all payor types, whereas implant-based reimbursement disparities are narrowing. CONCLUSIONS: We found that wide variations in reimbursement for breast reconstruction procedures exist and may preclude some surgeons from offering certain reconstructive options to a subset of patients. Understanding these discrepancies is a key first step in minimizing a potential care delivery disparity for this patient population.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Odom EB, Schmidt AC, Myckatyn TM, et al. A Cross-Sectional Study of Variations in Reimbursement for Breast Reconstruction: Is A Healthcare Disparity On the Horizon? Ann Plast Surg. 2018. PMID: 28984659. doi:10.1097/SAP.0000000000001228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。